Treatment of rheumatoid arthritis (RA) with monoclonal anti-tumor necrosis factor α antibody (anti-TNFα mAb) results in an accumulation of TH1 CD4+ T cells in the peripheral blood.

被引：0
|
作者：
Maurice, MM
van der Graaft, WL
Leow, A
Breedveld, FC
van Lier, RAW
Verweij, CL
机构：
[1] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[2] Red Cross Blood Transfus Serv, Cent Lab, Dept Clin Viroimmunol, Amsterdam, Netherlands
[3] Univ Amsterdam, Expt & Clin Immunol Lab, Amsterdam, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
798
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [21] TREATMENT WITH ANTI-TUMOR NECROSIS FACTOR (TNF) BIOLOGICS TO HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 (HTLV-1) POSITIVE PATIENTS WITH RHEUMATOID ARTHRITIS (RA) : A CASE-CONTROL STUDY
    Miyauchi, S.
    Umekita, K.
    Hidaka, T.
    Hashiba, Y.
    Kawaguchi, T.
    Matsuda, M.
    Kubo, K.
    Ueno, S.
    Kusumoto, N.
    Takajo, I.
    Kai, Y.
    Nagatomo, Y.
    Okayama, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 437 - 438
  • [22] T cell hypothesis in rheumatoid arthritis (RA) tested by humanized non-depleting anti-CD4 monoclonal antibody (mAb) treatment .3. Immunological effects.
    Connolly, DJA
    Choy, EHS
    Rapson, N
    Regan, T
    Kingsley, GH
    Johnston, JM
    Panayi, GS
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1302 - 1302
  • [23] Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-α monoclonal antibody in patients with rheumatoid arthritis
    den Broeder, AA
    Wanten, GJA
    Oyen, WJG
    Naber, T
    van Riel, PLCM
    Barrera, P
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (02) : 232 - 237
  • [24] Th1 type CD4(+) T cells may be a potent effector against poorly immunogenic syngeneic tumors - Anti-tumor activity of Th1 type CD4(+) T cells
    Terao, H
    Harada, M
    Kurosawa, S
    Shinomiya, Y
    Okamoto, T
    Ito, O
    Sumichika, H
    Takenoyama, M
    Nomoto, K
    BIOTHERAPY, 1995, 8 (02) : 143 - 151
  • [25] Effects of treatment with a fully human anti-tumour necrosis factor α monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFα in patients with rheumatoid arthritis
    Barrera, P
    Joosten, LAB
    den Broeder, AA
    van de Putte, LBA
    van Riel, PLCM
    van den Berg, WB
    ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (07) : 660 - 669
  • [26] Treatment of rheumatoid arthritis (RA) with anti-interferon (IFN)-g vs. anti-tumor necrosis factor (TNF)-a in randomized, double-blind, placebo-controlled trial.
    Lukina, G
    Sigidin, Y
    Pushkova, O
    Mach, E
    Skurkovich, B
    Skurkovich, S
    ARTHRITIS AND RHEUMATISM, 2003, 48 (12): : 3656 - 3656
  • [27] Anti-CD3 monoclonal antibody induces CD8+FOXP3+ regulatory T cells from the peripheral blood mononuclear cells of rheumatoid arthritis patients
    Ellis, S. D. P.
    Ehrenstein, M. R.
    Notley, C. A.
    IMMUNOLOGY, 2012, 136 : 6 - 6
  • [28] Decrease of NF-κB DNA-binding activity in peripheral blood mononuclear cells after treatment of rheumatoid arthritis with anti-TNF antibody infliximab.
    Voll, RE
    Dechant, C
    Bottcher, A
    Kolowos, W
    Herrmann, M
    Manger, B
    Kalden, JR
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S277 - S277
  • [29] Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy
    McGovern, Jenny L.
    Nguyen, Dao X.
    Notley, Clare A.
    Mauri, Claudia
    Isenberg, David A.
    Ehrenstein, Michael R.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : 3129 - 3138
  • [30] T cell hypothesis in rheumatoid arthritis (RA) tested by humanised non-depleting anti-CD4 monoclonal antibody (mAb) treatment .1. Suppression of disease activity and acute phase response.
    Panayi, GS
    Choy, EHS
    Connolly, DJA
    Manna, VK
    Regan, T
    Rapson, N
    Kingsley, GH
    Johnston, JM
    IMMUNOLOGY, 1996, 89 : OG379 - OG379
12345